Skip to main content

Advertisement

Log in

Therapeutic applications of vasopressin in pediatric patients

  • Review Article
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Context

Reports of successful use of vasopressin in various shock states and cardiac arrest has lead to the emergence of vasopressin therapy as a potentially major advancement in the management of critically ill children.

Objective

To provide an overview of physiology of vasopressin, rationale of its use and dose schedule in different disease states with special focus on recent advances in the therapeutic applications of vasopressin.

Data Source

MEDLINE search (1966–September 2011) using terms “vasopressin”, “terlipressin”, “arginine-vasopressin”, “shock”, “septic shock”, “vasodilatory shock”, “cardiac arrest”, and “resuscitation” for reports on vasopressin/terlipressin use in children and manual review of article bibliographies. Search was restricted to human studies. Randomized controlled trials, cohort studies, evaluation studies, case series, and case reports on vasopressin/terlipressin use in children (preterm neonates to 21 years of age) were included. Outcome measures were analysed using following clinical questions: indication, dose and duration of vasopressin/terlipressin use, main effects especially on systemic blood pressure, catecholamine requirement, urine output, serum lactate, adverse effects, and mortality.

Results

51 reports on vasopressin (30 reports) and terlipressin (21 reports) use in pediatric population were identified. A total of 602 patients received vasopressin/terlipressin as vasopressors in various catecholamine-resistant states (septic - 176, post-cardiotomy - 136, other vasodilatory/mixed shock — 199, and cardiac arrest - 101). Commonly reported responses include rapid improvement in systemic blood pressure, decline in concurrent catecholamine requirement, and increase in urine output; despite these effects, the mortality rates remained high.

Conclusion

In view of the limited clinical experience, and paucity of randomized controlled trials evaluating these drugs in pediatric population, currently no definitive recommendations on vasopressin/terlipressin use can be laid down. Nevertheless, available clinical data supports the use of vasopressin in critically ill children as a rescue therapy in refractory shock and cardiac arrest.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Du Vigneaud V, Gash DT, Karsoyannis PG. A synthetic preparation possessing biological properties associated with arginine vasopressin. J Am Chem Soc. 1954;76:4751–4752.

    Article  Google Scholar 

  2. Oliver H, Schafer E. On the physiological action of extracts of the pituitary body and certain other glandular organs: preliminary communication. J Physiol (Lond). 1895;18:277–279.

    CAS  Google Scholar 

  3. Turner RA, Pierce JG, Du Vigneaud V. The purification and the amino acid content of vasopressin preparation. J Biol Chem. 1951;191:21–28.

    PubMed  CAS  Google Scholar 

  4. Holmes CL, Landry DW, Granton JT. Science Review: Vasopressin and the cardiovascular system part-I — receptor physiology. Crit Care. 2003;7:427–434.

    Article  PubMed  Google Scholar 

  5. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001;120:989–1002.

    Article  PubMed  CAS  Google Scholar 

  6. Bourque CW, Oliet SH, Richard D. Osmoreceptors, osmoreception and osmoregulation. Front Neuroendocrinol. 1994;15:231–274.

    Article  PubMed  CAS  Google Scholar 

  7. Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35:33–40.

    Article  PubMed  CAS  Google Scholar 

  8. Treshcan TA, Peters J. The vasopressin system: Physiology and clinical strategies. Anesthesiology. 2006;105:599–612.

    Article  Google Scholar 

  9. Dunser MW, Hasibeder WR, Wenzel V, Schwarz S, Ulmer H, Knotzer H, et al. Endocrinologic response to vasopressin infusion in advanced vasodilatory shock. Crit Care Med. 2004;32:1266–1271.

    Article  PubMed  Google Scholar 

  10. Okamura T, Ayajiki K, Fujioka H, Toda N. Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries. J Hypertens. 1999;17:673–678.

    Article  PubMed  CAS  Google Scholar 

  11. Russ RD, Walker BR. Role of nitric oxide in vasopressinergic pulmonary vasodilatation. Am J Physiol. 1992;262:743–747.

    Google Scholar 

  12. Tayama E, Ueda T, Shojima T, Akasu K, Oda T, Fukunaga S, et al. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg. 2007;6:715–719.

    Article  PubMed  Google Scholar 

  13. Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Cortese G, et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med. 2004;30:597–604.

    Article  PubMed  Google Scholar 

  14. Haslam RJ, Rosson GM. Aggregation of human blood platelets by vasopressin. Am J Physiol. 1972;223:958–967.

    PubMed  CAS  Google Scholar 

  15. Douglas JG, Forrest JA, Prowse CV, Cash JD, Finlayson ND. Effects of lysine vasopressin and glypressin on the fibrinolytic system in cirrhosis. Gut. 1979;20:565–567.

    Article  PubMed  CAS  Google Scholar 

  16. Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK, et al. Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebo controlled clinical trial. J Gastroenterol Hepatol. 2003;18:152–156.

    Article  PubMed  CAS  Google Scholar 

  17. Richardson D, Robinson A. Desmopressin. Ann Intern Med. 1985;103:228–239.

    PubMed  CAS  Google Scholar 

  18. Key DW, Bloom DA, Sanvordenker J. Low-dose DDAVP in nocturnal enuresis. Clin Pediatr (Phila). 1992;31:299–301.

    Article  CAS  Google Scholar 

  19. Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, et al. Hemodynamic and coagulation responses to 1-desamino [8-d-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med. 1988;318:881–887.

    Article  PubMed  CAS  Google Scholar 

  20. Wise-Faberowski L, Soriano SG, Ferrari L, McManus ML, Wolfsdorf JI, Majzoub J, et al. Perioperative management of diabetes insipidus in children. J Neurosurg Anesthesiol. 2004;16:220–225.

    Article  PubMed  Google Scholar 

  21. Cochran EB, Phelps SJ, Tolley EA, Stidman GL. Prevalence of, and risk factors for upper gastrointestinal tract bleeding in critically ill pediatric patients. Crit Care Med. 1992;20:1519–1523.

    Article  PubMed  CAS  Google Scholar 

  22. Lacroix J, Nadeau D, Laberge S, Gauthier M, Lapierre G, Farrell CA. Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit. Crit Care Med. 1992;20:35–42.

    Article  PubMed  CAS  Google Scholar 

  23. Teach SJ, Fleisher GR. Rectal bleeding in the pediatric emergency department. Ann Emerg Med. 1994;23:1252–1258.

    Article  PubMed  CAS  Google Scholar 

  24. Darcy M. Treatment of lower gastrointestinal bleeding: Vasopressin infusion versus embolization. J Vasc Interv Radiol. 2003;14:535–543.

    Article  PubMed  Google Scholar 

  25. Molleston JP. Variceal bleeding in children. J Pediatr Gastroenterol Nutr. 2003;37:538–545.

    Article  PubMed  Google Scholar 

  26. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345:588–595.

    Article  PubMed  CAS  Google Scholar 

  27. Landry DW, Levin HR, Gallant EM, Ashton RC Jr., Seo S, D’Alessandro D, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122–1125.

    PubMed  CAS  Google Scholar 

  28. Lechner E, Dickerson HA, Fraser CD Jr, Chang AC. Vasodilatory shock after surgery for aortic valve endocarditis: Use of low-dose vasopressin. Pediatr Cardiol. 2004;25:558–561.

    Article  PubMed  CAS  Google Scholar 

  29. Liedel JL, Meadow W, Nachman, J, Koogler T, Kahana M. Use of vasopressin in refractory hypotension in children with vasodilatory shock: Five cases and a review of the literature. Pediatr Crit Care Med. 2002;3:15–18.

    Article  PubMed  Google Scholar 

  30. Choong K, Bohn D, Fraser DD, Gaboury I, Hutchison JS, Joffe AR, et al. Vasopressin in pediatric vasodilatory shock: A multicenter randomized controlled trial. Am J Resp Crit Care Med. 2009;180:632–639.

    Article  PubMed  CAS  Google Scholar 

  31. Yilidzdas D, Yapicioglu H, Celik U, Setdemir Y, Alhan E. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med. 2008;34:511–517.

    Article  Google Scholar 

  32. Ceneviva G, Paschall JA, Maffei F, Carcillo JA. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics. 1998;102:e19.

    Article  PubMed  CAS  Google Scholar 

  33. Brierley J, Carcillo JA, Choong K, Cornell T, DeCaen A, Deymann A, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009;37:666–688.

    Article  PubMed  Google Scholar 

  34. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998;116:973–980.

    Article  PubMed  CAS  Google Scholar 

  35. Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg. 2008;107:620–624.

    Article  PubMed  CAS  Google Scholar 

  36. Williams SR, Denault AY, Pellerin M, Martineau R. Vasopressin for treatment of shock following aprotinin administration. Can J Anaesth. 2004;51:169–172.

    Article  PubMed  Google Scholar 

  37. Chiara LD, Stazi GV, Ricci Z, Polito A, Morelli S, Giorni C, et al. Role of vasopressin in the treatment of anaphylactic shock in a child undergoing surgery for congenital heart disease: a case report. J Med Case Reports. 2008;2:36.

    Article  PubMed  Google Scholar 

  38. Meng L, Williams EL. Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin. Can J Anaesth. 2008;55:437–440.

    Article  PubMed  Google Scholar 

  39. Stadlbauer KH, Wenzel V, Krismer AC, Voelckel WG, Lindner KH. Vasopressin during uncontrolled hemorrhagic shock: Less bleeding below the diaphragm, more perfusion above. Anesth Analg. 2005;101:830–832.

    Article  PubMed  Google Scholar 

  40. Voelckel WG, Raedler C, Wenzel V, Lindner KH, Krismer AC, Schmittinger CA, et al. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med. 2003;31:1160–1165.

    Article  PubMed  CAS  Google Scholar 

  41. Haas T, Voelckel WG, Wiedermann F, Wenzel V, Lindner KH. Successful resuscitation of a traumatic cardiac arrest victim in hemorrhagic shock with vasopressin: a case report and brief review of the literature. J Trauma. 2004;57:177–179.

    Article  PubMed  Google Scholar 

  42. Erkek N, Senel S, Hizli S, Karacan CD. Terlipressin saved the life of a child with severe nonvariceal upper gastrointestinal bleeding. Am J Emerg Med. 2011;29:133. e 5–6.

    Article  PubMed  Google Scholar 

  43. Woodhouse SP, Cox S, Boyd P, Case C, Weber M. High dose and standard dose adrenaline do not alter survival compared with placebo in cardiac arrest. Resuscitation. 1995;30:243–249.

    Article  PubMed  CAS  Google Scholar 

  44. Perondi MB, Reis AG, Paiva EF, Nadkarni VM, Berg RA. A comparison of high-dose and standard dose epinephrine in children with cardiac arrest. N Engl J Med. 2004;350:1722–1730.

    Article  PubMed  CAS  Google Scholar 

  45. Stiell IG, Hébert PC, Wells GA, Vandemheen KL, Tang AS, Higginson LA, et al. Vasopressin versus epinephrine for in hospital cardiac arrest: a randomised controlled trial. Lancet. 2001;358:105–109.

    Article  PubMed  CAS  Google Scholar 

  46. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004;350:105–113.

    Article  PubMed  CAS  Google Scholar 

  47. Yilidzdas D, Horoz OO, Erdem S. Beneficial effects of terlipressin in pediatric cardiac arrest. Pediatr Emerg Care. 2011;27:865–868.

    Article  PubMed  Google Scholar 

  48. Gil-Antón J, López-Herce J, Morteruel E, Carrillo Á, Rodríguez-Núñez A. Pediatric cardiac arrest refractory to advanced life support: Is there a role for terlipressin? Pediatr Crit Care Med. 2010;11:139–141.

    Article  PubMed  Google Scholar 

  49. Mann K, Berg RA, Nadkarni V. Beneficial effects of vasopressin in prolonged pediatric cardiac arrest: a case series. Resuscitation. 2002;52:149–156.

    Article  PubMed  CAS  Google Scholar 

  50. Carroll TG, Dimas VV, Raymond TT. Vasopressin rescue for in-pediatric intensive care unit cardiopulmonary arrest refractory to initial epinephrine dosing: A prospective feasibility pilot trial. Pediatr Crit Care Med. 2011 Sep 15. [Epub ahead of print]

  51. Duncan MJ, Meaney P, Simpson P, Berg RA, Nadkarni V, Schexnayder S. Vasopressin for in-hospital pediatric cardiac arrest: Results from the American Heart Association National Registry of Cardiopulmonary Resuscitation. Pediatr Crit Care Med. 2009;10:191–195.

    Article  PubMed  Google Scholar 

  52. Wenzel V, Lindner KH, Prengel AW, Lurie KG, Strohmenger HU. Endobronchial vasopressin improves survival during cardiopulmonary resuscitation in pigs. Anesthesiology. 1997;86:1375–1381.

    Article  PubMed  CAS  Google Scholar 

  53. Katz K, Lawler J, Wax J, O’Connor R, Nadkarni V. Vasopressin pressor effects in critically ill children during evaluation for brain death and organ recovery. Resuscitation. 2000;47:33–40.

    Article  PubMed  CAS  Google Scholar 

  54. Papoff P, Caresta E, Versacci P, Grossi R, Midulla F, Moretti C. The role of terlipressin in the management of severe pulmonary hypertension in congenital diaphragmatic hernia. Pediatr Anaesth. 2009;19:805–806.

    Article  Google Scholar 

  55. Stathopoulos L, Nicaise C, Michel F, Thomachot L, Merrot T, Lagier P, et al. Terlipressin as rescue therapy for refractory pulmonary hypertension in a neonate with a congenital diaphragmatic hernia. J Pediatr Surg. 2011;46:19–21.

    Article  Google Scholar 

  56. Filippi L, Gozzini E, Daniotti M, Pagliai F, Catarzi S, Fiorini P. Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants. Pediatr Crit Care Med. 2011;12:e237–e241.

    Article  PubMed  Google Scholar 

  57. Scheurer MA, Bradley SM, Atz AM. Vasopressin to attenuate pulmonary hypertension and improve systemic blood pressure after correction of obstructed total anomalous pulmonary venous return. J Thorac Cardiovasc Surg. 2005;129:464–466.

    Article  PubMed  Google Scholar 

  58. Baldasso E, Garcia PCR, Piva JP, Branco RG, Tasker RC. Pilot safety study of low-dose vasopressin in non-septic critically ill children. Intensive Care Med. 2009;35:355–359.

    Article  PubMed  Google Scholar 

  59. Khilnani P, Singhi S, Lodha R, Santhanami I, Sachdev A, Chugh K, et al. Pediatric Sepsis Guidelines: Summary for resource-limited countries. Indian J Crit Care Med. 2010;14:41–52.

    Article  PubMed  Google Scholar 

  60. Kleinman ME, Chameides L, Schexnayder SM, Samson RA, Hazinski MF, Atkins DL, et al. Part 14: Pediatric Advanced Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122:876–908.

    Article  Google Scholar 

  61. Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, et al. Part 8. Adult advanced cardiovascular life support. American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122:729–767.

    Article  Google Scholar 

  62. Biarent D, Bingham R, Eich C, López-Herce J, Maconochie I, Rodríguez-Nunez A, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 6. Paediatric life support. Resuscitation. 2010;81:1364–1388.

    Article  PubMed  Google Scholar 

  63. Wenzel V, Lindner KH. Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor. Cardiovasc Res. 2001;51:529–541.

    Article  PubMed  CAS  Google Scholar 

  64. Vasopressins - Compound summary. Available from: URL: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11979316&loc=ec_rcs. Accessed August 30, 2011.

  65. Dünser MW, Mayr AJ, Tür A, Pajk W, Barbara F, Knotzer H, et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine resistant vasodilatory shock: Incidence and risk factors. Crit Care Med. 2003;31:1394–1398.

    Article  PubMed  Google Scholar 

  66. Rodriguez-Nunez A, Oulego-Erroz I, Gil-Anton J, Perez-Caballero C, Lopez-Herce J, Gaboli M, et al. Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock. Ann Pharmacother. 2010;44:1545–1553.

    Article  PubMed  CAS  Google Scholar 

  67. Bidegain M, Greenberg R, Simmons C, Dang C, Cotten MC, Smith BP. Vasopressin for refractory hypotension in extremely low birth weight infants. J Pediatr. 2010;157:502–504.

    Article  PubMed  Google Scholar 

  68. Ikegami H, Funato M, Tamai H, Wada H, Nabetani M, Nishihara M. Low-dose vasopressin infusion therapy for refractory hypotension in ELBW infants. Pediatr Int. 2010;52:368–373.

    Article  PubMed  CAS  Google Scholar 

  69. Papoff P, Mancuso M, Barbara CS, Moretti C. The role of terlipressin in pediatric septic shock: A review of the literature and personal experience. Int J Immunopathol Pharmacol. 2007;20:213–221.

    PubMed  CAS  Google Scholar 

  70. Rodriguez-Nunez A, Lopez-Herce J, Gil-Anton J, Hernandez A, Rey C. RETSPED: Working Group of the Spanish Society of Pediatric Intensive Care. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care. 2006;10:20.

    Article  Google Scholar 

  71. Meyer S, Loffler G, Polcher T, Gottschling S, Gortner L. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birth weight infants. Acta Paediatr. 2006;95:1309–1312.

    Article  PubMed  Google Scholar 

  72. Meyer S, Gottschling S, Baghai A, Wurm D, Gortner L. Arginine- vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury. Crit Care. 2006;10:71.

    Article  Google Scholar 

  73. Vasudevan A, Lodha R, Kabra SK. Vasopressin infusion in children with catecholamine resistant septic shock. Acta Pediatr. 2005;94:380–383.

    Article  CAS  Google Scholar 

  74. Matok I, Vard A, Efrati O, Rubinshtein M, Vishne T, Leibovitch L, et al. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock. 2005;23:305–310.

    Article  PubMed  CAS  Google Scholar 

  75. Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, Gonzalez-Alonso N, Martinon-Sanchez JM. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med. 2004;30:477–480.

    Article  PubMed  Google Scholar 

  76. Tobias JD. Arginine vasopressin for refractory distributive shock in two adolescents. J Intensive Care Med. 2002;17:48–52.

    Google Scholar 

  77. Agrawal A, Singh VK, Varma A, Sharma R. Intravenous arginine vasopressin infusion in refractory vasodilatory shock: A clinical study. Indian J Pediatr. 2011 Sep 16 [Epub ahead of print].

  78. Burton GL, Kaufman J, Goot BH, da Cruz EM. The use of arginine vasopressin in neonates following the Norwood procedure. Cardiol Young. 2011;21:536–544.

    Article  PubMed  Google Scholar 

  79. Alten JA, Borasino S, Toms R, Law MA, Moellinger A, Dabal RJ. Early initiation of arginine vasopressin infusion in neonates after complex cardiac surgery. Pediatr Crit Care Med. 2011 Sep 15 [Epub ahead of print].

  80. Mastropietro CW, Rossi NF, Clark JA, Walters HL III, Delius R, Lieh-Lai M, et al. Relative deficiency of arginine vasopressin in children after cardiopulmonary bypass. Crit Care Med. 2010;38:2052–2058.

    PubMed  CAS  Google Scholar 

  81. Matok I, Rubinshtein M, Levy A, Vardi A, Leibovitch L, Mishali D, et al. Terlipressin for children with extremely low cardiac output after open heart surgery. Ann Pharmacother. 2009;43:423–429.

    Article  PubMed  Google Scholar 

  82. Mastropietro CW, Clark JA, Delius RE, Walters HL III, Sarnaik AP. Arginine-vasopressin to manage hypoxic infants after stage I palliation of single ventricle lesions. Pediatr Crit Care Med. 2008;9:506–510.

    Article  PubMed  Google Scholar 

  83. Lechner E, Hofer A, Mair R, Moosbauer W, Sames-Dolzer E, Tulzer G. Arginine -vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass. Eur J Pediatr. 2007;166:1221–1227.

    Article  PubMed  CAS  Google Scholar 

  84. Rosenzweig EB, Starc TJ, Chen JM, Cullinane S, Timchak DM, Gersony WM, et al. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation. 1999;100(19 Suppl):II182–II186.

    PubMed  CAS  Google Scholar 

  85. Jerath N, Frndova H, McCrindle BW, Gurofsky R, Humpl T. Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients. Intensive Care Med. 2008;34:1274–1280.

    Article  PubMed  CAS  Google Scholar 

  86. Masutani S, Senzaki H, Ishido H, Taketazu M, Matsunaga T, Kobayashi T, et al. Vasopressin in the treatment of vasodilatory shock in children. Pediatr Int. 2005;47:132–136.

    Article  PubMed  CAS  Google Scholar 

  87. Efrati O, Modan-Moses D, Vardi A, Matok I, Bazilay Z, Paret G. Intravenous arginine vasopressin in critically ill children: Is it beneficial? Shock. 2004;22:213–217.

    Article  PubMed  CAS  Google Scholar 

  88. Matok I, Vardi A, Augarten A, Efrati O, Leibovitch L, Rubinshtien M, et al. Beneficial effects of terlipressin in prolonged pediatric cardiopulmonary resuscitation. A case series. Crit Care Med. 2007;35:1161–1164.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amit Agrawal.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agrawal, A., Singh, V.K., Varma, A. et al. Therapeutic applications of vasopressin in pediatric patients. Indian Pediatr 49, 297–305 (2012). https://doi.org/10.1007/s13312-012-0046-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-012-0046-0

Key words

Navigation